Evidence map›Paper›PMID 28803673›Full record

ArticleSeminars in arthritis and rheumatism2018

Tubulointerstitial damage predicts end stage renal disease in lupus nephritis with preserved to moderately impaired renal function: A retrospective cohort study.

Anna Broder, Wenzhu B Mowrey, Hina N Khan, Bojana Jovanovic, Alejandra Londono-Jimenez, Peter Izmirly, Chaim Putterman

Open access · greenAbstract read
In one paragraph

Article in Seminars in arthritis and rheumatism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 75 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Anna BroderDivision of Rheumatology, Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY. Electronic address: abroder@montefiore.org.
Wenzhu B MowreyDivision of Biostatistics, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY.
Hina N KhanDepartment of Medicine, Montefiore Medical Center, Bronx, NY.
Bojana JovanovicDivision of Rheumatology, Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.
Alejandra Londono-JimenezDepartment of Medicine, Montefiore Medical Center, Bronx, NY.
Peter IzmirlyDivision of Rheumatology, Department of Medicine, New York University School of Medicine, New York, NY.
Chaim PuttermanDivision of Rheumatology, Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.
Montefiore Medical Center · USAlbert Einstein College of Medicine · USNew York University · US

Funding

The impact of hydroxychloroquine use on thrombosis and mortality in lupus-related end stage renal diseaseK23AR068441 · NIAMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BRODER, ANNA · 2017 to 2021
$832k
NIAMS NIH HHS K23 AR068441
6 · The paper itself

Abstract

objectivesThe presence of tubulointerstitial damage (TID) on renal biopsy is considered to be a late sequela of lupus nephritis (LN). The objective of this study was to determine if TID predicts progression to end stage renal disease (ESRD) in LN patients without advanced kidney disease.

methodsAll SLE patients with an index biopsy consistent with LN between January 2005 and July 2015, and eGFR ≥ 30mL/min/1.73m

resultsOf the 131 LN patients with eGFR ≥ 30mL/min/1.73m

conclusionsModerate-to-severe TID, but not TII, was a strong predictor of ESRD progression independent of eGFR or glomerular findings, therefore, providing an important window for potential early interventions.

Indexed as

AdolescentAdultDisease ProgressionFemaleGlomerular Filtration RateHumansKidneyKidney Failure, ChronicLupus NephritisMaleMiddle AgedNephritis, InterstitialRetrospective StudiesYoung AdultEnd stage renal diseaseLupus nephritisTubulointerstitial damage

Identifiers

PMID28803673
PMCPMC5927553
OpenAlexW2734562167

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.